chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt developed left calf pain on 3/10/2022 and her family noted she had increased shortness of breath. She came into the office for evaluation for possible Deep vein thrombosis on 3/15/22. She was noticeably short of breath in office.  She had an ultrasound of the left leg and then a chest CT on 3/16/2022. The chest CT showed Peripheral pulmonary arterial thromboembolism right lower lobe. She was sent to the lab for coagulation studies and then started on Eliquis 3/16/2022.
Severe headache within 4 hours of shot and after 4 days of feeling very unwell Pt stood up and fell over instantly of and aneurysm and died  .I lost my partner of 23 years due to vaccination
Large area local reaction with redness and swelling and several small blisters. Mom gave Zyrtec, Benadryl and Tylenol.
small sore on vagina; This is a spontaneous report from a contactable nurse (patient).  A 24-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EH9899), intramuscular on 21Dec2020, at 16:00 as first single dose for covid-19 immunization.  The patient medical history was not reported.  Concomitant medication included ethinylestradiol, norgestimate (SPRINTEC).  The patient experienced a small sore on vagina on an unspecified date, after the vaccination. The outcome of small sore on vagina was recovered on an unspecified date.
Father reports child had seizure few hours after the vaccine given.  Child has had history of seizure over the past year not related to vaccines.  Child was admitted to hosp.over night.  09/21/2007 MR received for o/n ER admit for a 20 second episode of stiffness reported by parent. Child was standing when both arms flexed and the pt fell to the floor.  Eye deviation R&L. Lips turned white. No post-ictal state noted. D/C DX:  New onset seizures.
I experienced the expected symptoms such as chills, fever, muscle aches, etc - however, since my second dose on May 19, the muscle aches have remained.  Muscles feel weaker/fatigued in back, around joints, and lower body
The injection site is the left arm.  Common pain was felt, however, pain sensation traveled down below the left elbow. Persistent muscle cramping is experienced with the calf muscles of both legs.  A routine of stretching and daily mile walk before and after vaccination has not eliminated the pain.
pt recv vax & 4hr post vax pt exp fever, n/v;sx resolved w/in 24-48hr;
Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 11, 2023 PRESENTING PROBLEM: Hypoxemia Hypokalemia Weakness History of fall COVID-19   HOSPITAL COURSE: Patient is a 85 y.o. female with history of dementia, stage 3a CKD, hypothyroidism, hypertension, depression with anxiety and vitamin D deficiency who resides in Assisted Living Facility.  She was diagnosed with COVID-19 on 03/02 and had progressively worsening weakness and fall prompting ER visit. On presentation, she was hypoxemic and hypothermic.  D-dimer was elevated, CTA thorax was obtained and showed no PE, but did exhibit patchy and confluent areas of consolidation in the left lower lobe.  Both CT head and CT cervical spine were negative for acute pathology.  She had mild leukocytosis and procalcitonin was notably elevated at 2.19.  She was started on Decadron, remdesivir for COVID and IV Rocephin/doxycycline for suspected superimposed bacterial pneumonia.  Over the next 2 days patient was weaned to room air and respiratory symptoms improved.  Patient also had low potassium, magnesium, and phosphorus.  Electrolytes replaced and WNL at time of discharge.  PT/OT did recommend SAR, however placement would be delayed until 3/13 COVID isolation status.  The patient did have hospital delirium in the setting of dementia and acute infection.  Family preferred that the patient returned back to her home Assisted Living Facility. Care management was able to arrange for patient to have PT/OT 5 days per week and 24hr assistance with family.  Patient subsequently discharged back to Assisted Living Facility and stable condition.  She completed 4 days of IV antibiotics and was transition to PO Ceftin at discharge to complete total 5 day course.  Decadron and remdesivir stopped at discharge.
This is a spontaneous report from a contactable healthcare professional via a Pfizer-sales representative. A patient of unspecified age and gender received PREVNAR 13, via an unspecified route of administration on 22Oct2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient returned to the clinic on 25Oct2018 and reported having redness, swelling and heat couple inches of injection site on left arm in Oct2018. The patient was given 5 day oral treatment. Information on batch number has been requested.
Patient report that she has high fever, headache, facial twitching, & severe back pain.. Symptoms started an hour after she received the vaccine... also has numbness in her arm
Information has been received from the infectious disease division director at the Health Department and other unspecified reporters, referring to a 2 year old unspecified children of unknown gender (reported as "only 42 percent of 2-year old children"). This information had been collected in the article. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with the first dose of M-M-R II (strength, dose, anatomical location, administration route, lot number and expiration date were not reported) for prophylaxis. The reporter stated that the latest estimates showed that only 42 percent of 2-year old children had received their first M-M-R II shot (on unknown dates), which most health experts recommend at age 1 year old. Also reported that the second shot was administered when a child enters kindergarten, and produces highly effective immunity. However, on the statewide the vaccination rate was 88.5 percent.  The reporter stated that "whenever you had an outbreak in unvaccinated kids, measles just had a field day." Additional information has been requested.
Very bad pain at injection site and radiating into my chest, up my neck and down my arm.  Raising my arm is difficult  and extremely painful.
This initial spontaneous report was received on 19-JAN-2017 from a female licensed practical nurse (LPN) who reported that multiple unspecified patients over 14 years of age received either dose 2 or dose 3 of GARDASIL 9 one to two years after receiving the previous dose of GARDASIL 9 (unspecified dates) which is outside of the recommendations in the GARDASIL 9 prescribing information. The vaccination(s) route, site, Lot #, expiration date and indication were not reported. No adverse effect reported. No further information was reported. Additional information received on 20-JAN-2017, from the same female licensed practical nurse (LPN) reported the date(s) of the administration of GARDASIL 9 for this patient (gender not specified) was reported to be 1) 26-MAY-2015. No further information was reported. Additional information has been requested. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1701USA009269: US-009507513-1701USA009269: US-009507513-1701USA009269.
Information has been received from a nurse practitioner concerning a 7-year-old white female with drug reactions or allergies to AUGMENTIN, codeine, and KEFLEX and no other pertinent medical history who on 05-JUN-2000 was vaccinated with a subcutaneous 0.5 mL dose in the left arm of Varivax (lot # 634842/1867J). Concomitant therapy that day included a dose of MMR II. There was no other concomitant medication. On 02-APR-2006 the patient developed chickenpox breakthrough rash. The rash was seen on her arms, legs, back, and chin. The lesions were papular-vesicular. The child had a fever to 99.7. Unspecified medical attention was sought and she was treated with BENADRYL as needed and monitoring. As of 04-APR-2006 the patient was recovering. A product quality complaint was not involved. Additional information has been received from a medical assistant who reported that on 03-APR-2006 the patient had eight scattered papular-vesicular lesions. BENADRYL was given on her extremities and face. It was noted that she was exposed to chickenpox at school. The patient recovered on 08-APR-2006. Additional information is not expected.
The patient received improperly stored PROQUAD via intramuscular route; no adverse effects; The patient received improperly stored PROQUAD via intramuscular route; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concurrent conditions or drug reactions/allergies.    On 29-OCT-2019 the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), via intramuscular route (incorrect route of product administration), lot # S000621, expiration date 06-JUL-2020 for prophylaxis (dosage schedule and anatomical location were not provided) (product storage error). The vaccine was reconstituted with diluent MRK (lot number and expiration date were unknown by reporter). It was not specified if the diluent was stored properly. It was unknown by reporter the temperature excursion and time frame of the administered dose of  Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD). It was recorded by a data logger.  No adverse effects.
Patient's arm has been red, swollen, warm to the touch since receiving the Pfizer booster shot.  She has been using Tylenol, and compresses.  I told her to continue to do so, but seek medical treatment at the ER if the redness expands or gets worse, or persists.
Extreme body ache; Pain from shoulder to knee on the left arm; extreme fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Extreme body ache), PAIN IN EXTREMITY (Pain from shoulder to knee on the left arm), FATIGUE (extreme fatigue) and HEADACHE (Headache) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.  On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced FATIGUE (extreme fatigue) and HEADACHE (Headache). On an unknown date, the patient experienced PAIN (Extreme body ache) and PAIN IN EXTREMITY (Pain from shoulder to knee on the left arm). On 08-Mar-2021, FATIGUE (extreme fatigue) and HEADACHE (Headache) had resolved. At the time of the report, PAIN (Extreme body ache) and PAIN IN EXTREMITY (Pain from shoulder to knee on the left arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the patient had pain in both arms especially (left arm pain from shoulder to knee) and want to know if the given vaccine related as it was a delayed reaction.  No concomitant medication was reported.  It was not reported if the patient was received any corrective treatment for the event.
PATIENT REPORTED FEELING A "RUSH" LIKE HIS HEART WAS POUNDING.
Migraine for 2 days. High blood pressure - 164/98. Nausea. Blurry vision.
Severe chills began about 9 pm  1/23 lasting until 6 am the next morning 1/24.  Chills caused cramping of stomach and back of neck muscles.  Unsteady to walk.  Very painful.  Slept in fleece clothes under an electric blanket topped with a wool blanket and comforter.   Reduced chills by morning, more like all my other shots.  Steady on my feet again.  Stayed warm and slept most of 1/24.  Reporting as previous Covid shots gave me minor chills for a few hours, a slight headache and a sore arm.  1/26  I am reporting as this is the first clear head day since evening 1/23.
The first sign of pain was on the muscle of my left tight, my left shoulder and arm as well as  my neck, then my head. During the night continue increasing  the headache. In the morning hours I started developing low fever 99.4later it  increased Up to 100.8 . Have chilles most of the afternoon. All my body hurt. Developed a ?cold? from sinus to pain on the jaws, stuffy nose. No energy. Finally decided to take Tylenol. It helped to diminish the  fever and muscular pain but not the headache.
TESTED + FOR COVID  2-14-22                       ; DECEASED  2-15-22
Information has been received from a male Pharm. D. concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). The pharmacist reported that the patient experienced upper body rash. At the time of the report the patient's outcome was not reported. No further information is available.
Pt exp pain right foot & ankle,then stiffness & pain right wrist,pain both hands & swelling right index finger.Then pain both hands & wrist,left foot,left ankle,elbows & knees.Pt to MD & occupational health physician who felt rxn R/T vax.
Day 1:  egg-sized red raised area at sight of injection with a good deal of pain in upper left arm Day 2 am:  fever of 101.1 (normal 97.7F);  collapsed in kitchen with no dizziness;  extreme feeling of brain fog;  swollen lymph nodes under both arms;  chills;  headache;  fairly extreme pain at every  joint with prior injury--left knee, L4-L5 high right, 4th finger of right hand;  extreme fatigue, but inability to sleep though in bed all day Day 3  fever of 100; chills; swollen glands in both sides of neck;  still in bed with extreme fatigue and unable to sleep;  up for a couple of hours in early evening;  double vision; slept for two hours Day 4 am still with extreme fatigue and unable to sleep;  5am visual hallucinations while in bed and sitting on the side of bed;  still with double vision;  continuing large hot red area around injection site with upper arm pain To now as I am writing this, continued fatigue and general malaise, double vision now gone.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2012, the patient was inoculated with ZOSTAVAX at a physician's office as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 07-JUL-2016, the patient was treated at a medical office for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. He was prescribed triamcinolone acetonide (KENALOG) and acetaminophen and hydrocodone (NORCO) for management of his painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Information has been received from an 82 year old female with no known allergies with diabetes, high cholesterol and high blood pressure who on 14-AUG-2007 was vaccinated with Zostavax (Oka/Merck). Concomitant therapy included unspecified diabetic and cholesterol pill and multivitamins (unspecified). The patient reported that she developed shingles on 04-SEP-2007 as diagnosed by her physician. The patient reported she experienced pain under her arm and on the side of her breast where also 6 to 7 lesions were present. Diagnostic tests were performed periodically. The patient's shingles persisted. Additional information was requested.
Pt had onset of unexplained dizziness about a week after receiving the vaccinations. He is still experiencing this.
I am an epidemiologist and after vaccine I slept for 18 hours, unbroken. The next morning, I got up ran 5 miles. I would say in April 2021, I starting to notice having severe knee pain, went to orthopedic doctor. I have had MS, for like 15 years, this is brand new thing of my symptoms and now I think I might have RA. I am actually going to get couple of MRI's of the brain few days also of  my temporal arteries to check for spasm and inflammation. This happened about 3 weeks to a month post vaccine. I am not sure what is happening. I have concerns about my symptoms being related to the vaccine.
6 hours after vaccination, patient reported hives all over her body. She took Benadryl by mouth and applied Benadryl cream. She also reported joint pain. Next morning, hives were slightly better  but not gone so patient took more benadryl. Patient also reports feeling a little dizzy this morning especially when she turns around.
Very sore red arm about 2x3inches in size on arm. Can't sleep on side of arm hurting.
positive COVID-19 Test; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (positive COVID-19 Test) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (positive COVID-19 Test). At the time of the report, SARS-COV-2 TEST POSITIVE (positive COVID-19 Test) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
no adverse effect; received improperly stored varivax; This spontaneous report as received from a nurse refers to a patient of demographics. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies were not reported.   On 20-AUG-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot # R019237 with expiration date: 04-JUL-2020 or lot # S005078 with expiration date: 19-FEB-2021 (strength, dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). The vaccines were reconstituted with properly stored sterile diluent. The vaccines exposed to a temperature of  -14 degree celsius to -10 degree Celsius (-9.74 degree celsius). There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.
the patient's INR was fluctuating; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  An 85-year-old female patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Lot number: HF5024, Expiration Date: 28Feb2025) for immunisation. The patient's relevant medical history was not reported. Concomitant medications included: WARFARIN; COUMADIN. The following information was reported: INTERNATIONAL NORMALISED RATIO FLUCTUATION (non-serious), outcome "unknown", described as "the patient's INR was fluctuating". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of international normalised ratio fluctuation.  Additional information: INR has been fluctuating a lot since she received the RSV vaccine; INR was 1.8 today when it has been holding steady between 2.2 and 2.3 for the last four weeks. She takes Warfarin or Coumadin as other Medical Conditions and Concomitant medications.
Client received Prevnar 20 vaccination on 06/08/22, data base was not updated, and client was given a second dose of Prevnar 20 on 10/28/22.
Patient reporting pain/soreness in arm/shoulder. Patient says pain still in area. Patient believes may be related to flu shot.
fever 102.3 at 1:45pm  tylenol 650mg given at 1:55pm
The patient received a dose of Moderna for her first preliminary dose even though this vaccine is not recommended for her age. No major side effects occurred after receiving the dose so far. The patient's mother will continue to monitor and will report to the child's pediatrician if any adverse reactions occur.
1 day after Td (left arm) and varivax (right arm), developed redness at left arm site; tender left upper arm shoulder left and right mid anterior cervical lymph nodes, slight edema of upper arm and shoulder.  Decreased range of motion left shoulder due to pain. Prescription: Benadryl, Motrin.  Follow up on 11/26/03: "Please check manu below-mail original. "
Felt a dull headache a few hours after vaccine and for a few days afterward, and felt dull soreness on left arm (site of injection) and left leg the day of and the day after the injection.
eye is swollen / swelling of his eye; Fatigue; pain in his arm where he received the injection /  pain in his arm; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th February 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 1st March 2021, 1 days after receiving Shingrix, the patient experienced fatigue and pain in arm. On 3rd March 2021, the patient experienced eye swelling. On 3rd March 2021, the outcome of the fatigue was recovered/resolved. On an unknown date, the outcome of the pain in arm and eye swelling were not recovered/not resolved.   It was unknown if the reporter considered the fatigue, pain in arm and eye swelling to be related to Shingrix.  Additional details were provided as follows:  The patient received the 2nd dose of Shingrix in left deltoid. The patient experienced woke up with fatigue and pain in his arm where he received the injection and eye was swollen. The caller reported that the patient was asking if that could be from the Shingrix. The patient was still experiencing pain in his arm and swelling of his eye. Provided medical disclaimer and advised to follow up with health care professional. The caller declined to provide any HCP information. Health care professional information not provided The reporter did not consent to follow up.
Vaccine may have been administered after expiration date; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine may have been administered after expiration date) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine may have been administered after expiration date). On 19-Feb-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine may have been administered after expiration date) had resolved.            No concomitant medications were reported.  No treatment medications were reported.